v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Expenses:    
General and Administrative $ 1,612,267 $ 1,489,398
Research and Development 2,123,725 2,531,887
Collaboration Credits (1,233,224) (1,966,123)
Change in Fair Value of Contingent Consideration 7,427 275,192
Total Operating Expenses 2,510,195 2,330,354
Operating Loss (2,510,195) (2,330,354)
Other Income (Expense), Net:    
Interest Income, Net 139,338 276,633
Other Expense, Net (47,127) (16,253)
Total Other Income, Net 92,212 260,380
Loss Before Income Tax Provision (2,417,984) (2,069,974)
Income Tax Provision 0 (123,006)
Net Loss (2,417,984) (2,192,980)
Net Loss Attributable to Common Shareholders (2,417,984) (2,192,980)
Net Loss Attributable to Common Shareholders $ (2,417,984) $ (2,192,980)
Net Loss per Common Share - Basic (in usd per share) $ (0.58) $ (0.52)
Weighted Average Shares Outstanding - Basic (in shares) 4,174,802 4,217,007
Net Loss per Common Share - Diluted (in usd per share) $ (0.58) $ (0.52)
Weighted Average Shares Outstanding - Diluted (in shares) 4,174,802 4,217,007
Other Comprehensive Loss:    
Net Loss $ (2,417,984) $ (2,192,980)
Unrealized Loss on Marketable Securities (8,353) (16,099)
Foreign Currency Translation Adjustments 25,694 1,072
Comprehensive Loss $ (2,400,643) $ (2,208,007)

Source

10-Q PDF XBRL Zip